FDA Approved: ADVAIR HFA — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

This document records the original FDA approval of Advair HFA, a combination inhaled therapy of fluticasone propionate and salmeterol xinafoate, developed by Gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair HFA (fluticasone propionate/salmeterol)

Snippet

ORIG AP for ADVAIR HFA (FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE)